Panelists discuss how patient-specific factors like age, comorbidities, cytogenetic risk status, and personal preferences guide decisions to deviate from standard protocols, with particular attention to frailty scores and organ function when considering treatment intensity.
Video content above is prompted by the following:
Stay up to date on recent advances in the multidisciplinary approach to cancer.